Results 221 to 230 of about 20,698 (251)

Cardiovascular Outcomes of GLP‐1–Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta‐Analyses of Randomized Controlled Trials

open access: yesObesity Reviews, EarlyView.
ABSTRACT Introduction Cardiovascular (CV) outcomes of Glucagon‐like peptide‐1 (GLP‐1)–based medicines among people with overweight and obese (OW/OB) population have been investigated by meta‐analyses of randomized controlled trials (RCTs), but an overall summary is lacking.
Muhammed Rashid   +6 more
wiley   +1 more source

One Size Fits None: Developing a Person‐Centered Approach to Weight Management in Older Adults

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Aruna V. Josyula   +6 more
wiley   +1 more source

Effects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review. [PDF]

open access: yesNeth Heart J
van Maren SJF   +5 more
europepmc   +1 more source

Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice. [PDF]

open access: yesiScience
Ding M   +10 more
europepmc   +1 more source

Error in Discussion.

open access: yesJAMA Ophthalmol
europepmc   +1 more source

Home - About - Disclaimer - Privacy